Integer Holdings Corporation announced on October 24, 2025 that Payman Khales has assumed the positions of President and Chief Executive Officer and has joined the company’s Board of Directors. Khales succeeds Joseph Dziedzic, who is retiring after eight years of service as President and CEO and will continue as an advisor through March 31, 2026.
Prior to joining Integer, Khales served as President of the Cardio & Vascular business, where he led a customer‑focused strategy that doubled sales over seven years and improved service levels and profitability. Most recently he was Chief Operating Officer, overseeing both business units and global operations, and has been instrumental in expanding Integer’s manufacturing and development capabilities.
The leadership transition is expected to provide continuity in Integer’s growth strategy while bringing Khales’ operational expertise to the top of the organization. His appointment reinforces the company’s focus on high‑growth medical device markets and its commitment to delivering value to OEM partners, positioning Integer for continued expansion in electrophysiology, structural heart, and neuromodulation segments.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.